Topical Therapy in Thygeson’s Superficial Punctate Keratitis
When someone is affected by the severity of Thygeson’s Superficial Punctate Keratitis or in any of its signs, symptoms, or following remission, various therapies are considered depending on the severity of the disease at the time the patient presents to the eye care specialist. Where a patient presents with a mild case, then they may […]
Corticosteroids and Cyclosporine Treatments for Thygeson’s SPK
Studying the opacities or lesions created by Thygeson’s SPK, also known as Thygeson’s Superficial Punctate Keratopathy, Thygeson’s Superficial Punctate Keratitis and TSPK, shows a crystalline appearance on the corneal surface that resemble snowflakes. They vary in location and fluctuate in numbers even on a weekly basis during a flare up of the condition affecting the […]
Patient Education Relating to Thygeson’s Superficial Punctate Keratitis (TSPK)
Patient education relating to Thygeson’s Superficial Punctate Keratitis (TSPK) is an ongoing process that begins with diagnosis and continues through the entire term of the patient-doctor relationship as the patient battles the disease, attempting to manage the disease long-term. The cause or causes of Thygeson’s Superficial Punctate Keratitis (TSPK) have not yet been determined, but […]
Thygeson’s Superficial Punctate Keratitis (TSPK) Treatment Complications
The good news is that Thygeson’s Superficial Punctate Keratitis (TSPK) complications are far fewer than when the disease was first presented to the medical community in 1950.There are irritating symptoms such as chronic dry eye, burning sensations that come and go in the eyes, a high degree of sensitivity to bright lights or even sunshine […]
Thygeson’s Superficial Punctate Keratitis Medication
There are different types of eye drops commonly used for the treatment of the symptoms of Thygeson’s Superficial Punctate Keratitis. No Thygeson’s Superficial Punctate Keratitis medication is currently available that will cure the eye condition. Fluorometholone is used to reduce inflammation and neovascularization in the cornea while limiting the movement of polymorphonuclear leukocytes and reversing […]
The Pathophysiology of Thygeson’s SPK
Many specialists have studied the pathophysiology of Thygeson’s Superficial Punctate Keratitis (TSPK) by documenting all known biology and physical symptoms pertaining to patients. This disease has confounded medical doctors, researchers, and laboratory workers for decades. The knowledge gained since Phillips Thygeson first published a paper on TSPK in the AMA Journal in 1950 has mostly […]